Bausch Health Companies Inc. BHC

About Bausch Health Companies Inc. (BHC): stock profile, AI score and financials

Bausch Health Companies Inc. (BHC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BHC at 53.1/100 on a composite quality score built from its SEC filings, placing it at rank #1,423 of 2,925 stocks — the top half of the AI-ranked universe. BHC scores in the top quartile across revenue scale (87.0), earnings quality (77.7). Areas of concern include profitability (18.2) and balance sheet strength (23.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 38.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Bausch Health Companies Inc. reports quarterly revenue of $2.9B, net income of $258.0M, an operating margin of 25.9%. Top institutional holders of BHC by reported 13-F value include PAULSON, GOLDENTREE ASSET MANAGEMENT, ROYAL BANK OF CANADA, based on the most recent SEC filings. BHC trades on the NYSE exchange and files with the SEC under CIK 885590. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bausch Health Companies Inc. directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 885590 →